UPDATED on 12/12/2022 Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software https://pharmaceuticalintelligence.com/2022/12/13/mission-4-use-of-systems-biology-for-design-of-inhibitor-of-galectins-as-cancer-therapeutic-strategy-and-software/ UPDATED on 10/10/2022 Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners https://pharmaceuticalintelligence.com/2022/10/11/endoglin-protein-interactome-profiling-identifies-trim21-and-galectin-3-as-new-binding-partners/ UPDATED on 9/1/2022 The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in … Continue reading Synthetic Biology in Drug Discovery